Our integrated approach to drug discovery and development combines our libraries of kinase-focused compounds and proprietary analytical tools with expertise in medicinal chemistry, molecular and cellular biology, pharmacology and pharmacokinetics. This approach has enabled us to build a pipeline of potent and selective drug candidates. We intend to continue to leverage our tools and expertise to expand our existing pipeline through the discovery and development of additional small molecule kinase inhibitors.